Health
Putting the ‘STING’ on CAR-T cells to turn them against breast cancer and other solid tumors – FierceBiotech
Activating the immune pathway STING creates an inflammatory environment that should improve immuno-oncology treatments, but clinical trials have been disappointing…
The immune pathway known as stimulator of interferon genes (STING) has long been of interest in the oncology community because activating it creates an inflammatory environment that should improve the ability of immune cells to attack cancer. But experimental STING-activating treatments have produced mixed results in clinical trials.
Researchers at the University of North Carolina (UNC) Lineberger Comprehensive Cancer Center have promising evidence that adding STING activators to CAR-T cell therapies…
-
Noosa News11 hours agoTeenage girl killed in alleged hit-and-run at Margate north of Brisbane
-
Noosa News9 hours agoTeenage girl dies in hit-and-run, police hunt for ute
-
Noosa News23 hours agoNRL legend Trevor Gillmeister charged with assaulting police officer at Brisbane pub
-
Noosa News4 hours ago‘Beyond devastated’ Brisbane family learn missing German shepherd Arnie found dead in back of stolen car